599 related articles for article (PubMed ID: 20378670)
1. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
Hirsch EB; Tam VH
J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670
[TBL] [Abstract][Full Text] [Related]
2. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Rapp RP; Urban C
Pharmacotherapy; 2012 May; 32(5):399-407. PubMed ID: 22488420
[TBL] [Abstract][Full Text] [Related]
3. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
4. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.
Tsakris A; Kristo I; Poulou A; Markou F; Ikonomidis A; Pournaras S
J Antimicrob Chemother; 2008 Dec; 62(6):1257-60. PubMed ID: 18772158
[TBL] [Abstract][Full Text] [Related]
5. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
6. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Nadkarni AS; Schliep T; Khan L; Zeana CB
Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
[TBL] [Abstract][Full Text] [Related]
7. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
8. The current state of multidrug-resistant gram-negative bacilli in North America.
Nicasio AM; Kuti JL; Nicolau DP
Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
[TBL] [Abstract][Full Text] [Related]
9. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
[No Abstract] [Full Text] [Related]
10. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
14. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.
Mezzatesta ML; Gona F; Caio C; Petrolito V; Sciortino D; Sciacca A; Santangelo C; Stefani S
Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
17. KPC-2 carbapenemase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis.
Leão RS; Pereira RH; Folescu TW; Albano RM; Santos EA; Junior LG; Marques EA
J Cyst Fibros; 2011 Mar; 10(2):140-2. PubMed ID: 21220216
[TBL] [Abstract][Full Text] [Related]
18. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Lee GC; Burgess DS
Ann Clin Microbiol Antimicrob; 2012 Dec; 11():32. PubMed ID: 23234297
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).
Maltezou HC; Giakkoupi P; Maragos A; Bolikas M; Raftopoulos V; Papahatzaki H; Vrouhos G; Liakou V; Vatopoulos AC
J Infect; 2009 Mar; 58(3):213-9. PubMed ID: 19246099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
